IDMP: identification of medicinal products

IDMP (identification of medicinal products) is a set of five ISO standards for describing medicines, implemented in the EU through EMA's SPOR services.

Also known as: ISO IDMP, ISO IDMP standards

3 min readUpdated

Reviewed by Gosia Luksza, CEO at Regunaut

At a glance

Standards
ISO 11615, 11616, 11238, 11239 and 11240
Legal basis
Articles 25 and 26 of Implementing Regulation (EU) No 520/2012
EU implementation
EMA's SPOR services for substances, products, organisations and referentials
Replaces
The xEVPRM format of the Article 57 database, in phases

How it works

IDMP stands for identification of medicinal products. It is a suite of five standards from the International Organization for Standardization that define the data elements, formats and terminologies for describing a medicine unambiguously, so that regulators, companies and healthcare systems in different countries can exchange information about a product and know they mean the same thing. ISO 11615 covers regulated medicinal product information, such as the authorisation, the holder, the packaging and the manufacturers. ISO 11616 covers regulated pharmaceutical product information, which describes a product by substance, strength and dose form independently of brand and country. ISO 11238 covers substances, ISO 11239 pharmaceutical dose forms, units of presentation, routes of administration and packaging, and ISO 11240 units of measurement.

In the EU the standards are a legal requirement. Articles 25 and 26 of Commission Implementing Regulation (EU) No 520/2012 oblige Member States, marketing authorisation holders and EMA to use them, and Article 57(2) of Regulation (EC) No 726/2004 already requires holders to submit and maintain data on every authorised medicine. EMA implements the standards in phases through the SPOR programme, which divides the master data into four domains with a service for each: substances (SMS), products (PMS), organisations (OMS) and referentials (RMS). The organisation and referentials services came first and are used in the electronic application forms, IRIS and the PLM Portal. The product and substance services are being built up in stages.

For a holder, IDMP mostly means product data. Submitting data on authorised medicines has been mandatory since July 2012 in the xEVPRM format of the Article 57 database, and EMA has stated that this format will be replaced by one compatible with ISO IDMP. Product records are being migrated into the Product Management Service, and the web-based application forms draw on them, so that a variation is recorded against structured data instead of free text. EMA's EU IDMP Implementation Guide sets out the data elements and the rules for exchanging them. The practical work is the same whatever the timetable: finding where each data element lives today, in the dossier, the product information, a regulatory information management system or a spreadsheet, and making one source authoritative.

What goes wrong

Treating IDMP as an IT project when most of the effort is data ownership and cleaning; product data in PMS, the Article 57 record and the approved SmPC that disagree with each other; substances, dose forms or sites that have no entry in the EMA services, discovered when a form cannot be completed; identifiers mapped once for a migration and never maintained; and waiting for a final mandatory date before starting, when the application forms already depend on the data. Companies with products in several regions also find that each regulator implements the same standards differently, so the EU data model cannot simply be reused elsewhere.

What teams do with it in Regunaut

One job in the platform that turn on IDMP, each part of a wider workflow.

What the 2026 EU pharma package changes

Under the new pharma package (not yet in force), some changes to a marketing authorisation can be made as updates by the holder of its information held in a database, with the qualifying changes left to Commission delegated acts, which would make the quality of structured product data a regulatory matter in its own right; see variations changes.

IDMP: common questions

What are the five ISO IDMP standards?

ISO 11615 for regulated medicinal product information, ISO 11616 for regulated pharmaceutical product information, ISO 11238 for substances, ISO 11239 for pharmaceutical dose forms, units of presentation, routes of administration and packaging, and ISO 11240 for units of measurement. Together they define how a medicine is described so that the same product can be identified across systems and countries.

Is IDMP mandatory in the EU?

The use of the ISO IDMP standards is required by Articles 25 and 26 of Implementing Regulation (EU) No 520/2012, and EMA is implementing them in phases through the SPOR services. Organisation and referential data from OMS and RMS are already required in the electronic application forms. Product data are still submitted to the Article 57 database in the xEVPRM format until EMA replaces it with an IDMP-compatible one.

What is the difference between IDMP and SPOR?

IDMP is the set of international ISO standards. SPOR is how EMA puts them into practice in the EU: four data management services for substances, products, organisations and referentials, whose identifiers and terms are used in application forms and submissions. A company complies with IDMP in the EU by supplying and maintaining its data through those services.

Sources

  1. European Medicines Agency: Data on medicines (ISO IDMP standards): overview
  2. EUR-Lex: Commission Implementing Regulation (EU) No 520/2012 on the performance of pharmacovigilance activities (Articles 25 and 26)

Put your IDMP question to Workbench

Workbench answers regulatory questions from EUR-Lex, EMA, national agencies and your own documents, with every claim linked to its source. Start free with welcome credits.